Cargando…

The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution

PURPOSE: To explore whether changes in tumor size impact survival in advanced non-small-cell lung cancer (NSCLC) after target therapy, especially in patients with evaluation of stable disease (SD), and to review the applicability of the Response Evaluation Criteria in Solid Tumors (RECIST) criteria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jianwei, Huang, Yan, Li, Xiaoling, Guo, Ying, Zhao, Yuanyuan, Xue, Cong, Hu, Zhihuang, Zhang, Li, Zhao, Hongyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501954/ https://www.ncbi.nlm.nih.gov/pubmed/23172990 http://dx.doi.org/10.2147/OTT.S38441

Ejemplares similares

The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment
por: Zhou, Ting, et al.
Publicado: (2015)

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC
por: Wu, Xuan, et al.
Publicado: (2013)

Optimal tumor shrinkage predicts long-term outcome in advanced nonsmall cell lung cancer (NSCLC) treated with target therapy: Result from 3 clinical trials of advanced NSCLC by 1 institution
por: He, Xiaobo, et al.
Publicado: (2016)

The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations
por: Xin, Shuang, et al.
Publicado: (2015)

Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment
por: Zhao, Hongyun, et al.
Publicado: (2013)

UNDERSTANDING CAREGIVER PERSPECTIVES ON LIVE DISCHARGE AND RE-ENROLLMENT ONTO HOSPICE CARE
por: Wladkowski, Stephanie P
Publicado: (2022)

Owner-Reported Pica in Domestic Cats Enrolled onto a Birth Cohort Study
por: Kinsman, Rachel, et al.
Publicado: (2021)

Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
por: Zhou, Ting, et al.
Publicado: (2015)

PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
por: Fang, Wenfeng, et al.
Publicado: (2015)

Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2015)

Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy
por: Hu, Zhihuang, et al.
Publicado: (2016)

EGFR mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients
por: Zheng, Qiufan, et al.
Publicado: (2020)

The institutional experience of the implementing 4DCT in NSCLC radiotherapy planning
por: Dang, Huy Quang, et al.
Publicado: (2023)

Mundane? Demographic characteristics as predictors of enrolment onto the National Health Insurance Scheme in two districts of Ghana
por: Seddoh, Anthony, et al.
Publicado: (2018)

A Large-scale Cross-sectional Study of ALK Rearrangements and EGFR Mutations in Non-small-cell Lung Cancer in Chinese Han Population
por: Hong, Shaodong, et al.
Publicado: (2014)

Afatinib as a Potential Therapeutic Option for Patients With NSCLC With EGFR G724S
por: Wei, Yang, et al.
Publicado: (2021)

The overall survival benefit in Chinese ALK(+) NSCLC patients received targeted therapies
por: Tian, Guangming, et al.
Publicado: (2022)

Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China
por: Zhang, Lei, et al.
Publicado: (2015)

Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
por: Liang, Wenhua, et al.
Publicado: (2014)

Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis
por: Zhang, Yaxiong, et al.
Publicado: (2016)

Characterizing Academic Help-seeking Moods for Enrollment Performance of Institutional Online Student
por: Shi, Hongwei, et al.
Publicado: (2021)

Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

Aggregate Size Dependence of Amyloid Adsorption onto Charged Interfaces
por: Tesei, Giulio, et al.
Publicado: (2017)

A clinical variable‐based nomogram could predict the survival for advanced NSCLC patients receiving second‐line atezolizumab
por: Shang, Xiaoling, et al.
Publicado: (2021)

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era
por: Roth, Michael E., et al.
Publicado: (2020)

Analysis of MAT3 gene expression in NSCLC
por: Zheng, Shangen, et al.
Publicado: (2013)

Myeloid cell leukemia-1 is an important predictor of survival and progression of small cell lung cancer
por: Zhou, Ting, et al.
Publicado: (2020)

A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

Resetting Prices: Estimating the Effect of Tuition Reset Policies on Institutional Finances and Enrollment
por: Ward, James Dean, et al.
Publicado: (2022)

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials
por: Hong, Shaodong, et al.
Publicado: (2014)

TRLS-03. Intracranial activity of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC enrolled in VISION
por: Bestvina, Christine M, et al.
Publicado: (2021)

SYST-06 INTRACRANIAL ACTIVITY OF TEPOTINIB IN PATIENTS WITH MET EXON 14 (METEX14) SKIPPING NSCLC ENROLLED IN VISION
por: Leighl, Natasha, et al.
Publicado: (2022)

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
por: Fang, Wenfeng, et al.
Publicado: (2014)

Soft landing of polyatomic anions onto three-dimensional semiconductive and conductive substrates
por: Gholipour-Ranjbar, Habib, et al.
Publicado: (2023)

Disparities in the enrollment to systemic therapy and survival for patients with multiple myeloma()
por: Jayakrishnan, Thejus T., et al.
Publicado: (2021)

Will colleges survive the storm of declining enrollments? A computational model
por: Pavlov, Oleg V., et al.
Publicado: (2020)

Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC
por: Wei, Yongyue, et al.
Publicado: (2018)

Numbers and Stations: Impact of Examined Lymph Node on Precise Staging and Survival of Radiologically Pure-Solid NSCLC: A Multi-Institutional Study
por: Chen, Donglai, et al.
Publicado: (2020)

Expression of EGFR Is Closely Related to Reduced 3-Year Survival Rate in Chinese Female NSCLC
por: Sun, Guangyuan, et al.
Publicado: (2015)

A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab
por: Lin, Jiamao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7eqeie3ca4utap2gv6bk3me9lm